Perioperative systemic chemo-immunotherapy for upper urinary tract urothelial carcinoma

To assess the effects of perioperative systemic chemotherapy or immunotherapy (or both) for UTUC.

This is a protocol.

Health topics:

Cancer > Bladder

Urology > Cancer > Bladder cancer

Urology > Cancer > Other urologic cancers

Published:

16 April 2020

Authors:

Hwang E, Sathianathen NJ, Jung J, Kim M, Narayan V, Hwang J, Spiess PE., Dahm P

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Hwang E, Sathianathen NJ, Jung J, Kim M, Narayan V, Hwang J, Spiess PE., Dahm P. Perioperative systemic chemo-immunotherapy for upper urinary tract urothelial carcinoma. Cochrane Database of Systematic Reviews 2020, Issue 3. Art. No.: CD013567. DOI: 10.1002/14651858.CD013567